Zusammenfassung
Pharmakokinetische Modelle können in physiologisch basierte und empirische Modelle unterschieden werden. Traditionell erfolgt die Beschreibung der Pharmakokinetik volatiler Anästhetika mithilfe physiologisch basierter Modelle unter Verwendung der jeweiligen Gewebe-Blut-Verteilungskoeffizienten. Die Kompartimente des empirischen Modells weisen kein anatomisches Korrelat auf, sondern sind durch das mathematische Verfahren der Parameterabschätzung entstanden. Die endexspiratorische Konzentration von volatilen Anästhetika entspricht nahezu der arteriellen Konzentration, daher kommt der Beschreibung des Übertritts zwischen Plasma und Wirkort für volatile Anästhetika eine zentrale Rolle zu. Der wichtigste Parameter ist hierbei der ke0-Wert; dieser ist eine zeitliche Konstante und beschreibt die zeitliche Verzögerung beim Übergang zwischen dem zentralen Kompartiment und dem berechneten Effektkompartiment. Die ke0-Werte für Sevofluran und Isofluran unterscheiden sich nicht; der Konzentrationsausgleich zwischen dem Zentral- und dem Effektkompartiment bei Desfluran hingegen erfolgt doppelt so schnell. In der klinischen Praxis werden volatile Anästhetika in der Regel mit N2O und/oder Opioiden kombiniert. Dabei ergibt sich eine additive Interaktion von volatilen Anästhetika und N2O. Die Interaktion zwischen volatilen Anästhetika und Opioiden ist hingegen synergistisch. Für die klinisch weit verbreitete Dreifachkombination von volatilen Anästhetika, N2O und Opioiden liegen hingegen kaum Interaktionsuntersuchungen vor.
Abstract
Pharmacokinetic models can be differentiated into two groups: physiological-based models and empirical models. Traditionally the pharmacokinetics of volatile anaesthetics are described using physiological-based models together with the respective tissue-blood distribution coefficients. The compartments of the empirical model have no anatomical equivalents and are merely the product of the mathematical procedure for parameter estimation. The end expiratory concentration of volatile anaesthetics is approximately equal to the arterial concentration and, therefore, the description of the transition between plasma and effect site for volatile anaesthetics plays a central role. The most important parameter here is the ke0 value which is a time constant and describes the time delay for the transition from the central compartment to the calculated effect compartment. The ke0 values for sevoflurane and isoflurane are the same but the concentration balance between the end-tidal concentration and the effect compartment occurs twice as quickly with desflurane. In clinical practice volatile anaesthetics are normally combined with N2O and/or opioids. This results in an additive interaction between volatile anaesthetics and N2O but a synergistic interaction of volatile anaesthetics with opioids. However, there are relatively few investigations on the interactions between the clinically widely used combination of volatile anaesthetics, N2O and opioids.
Literatur
Anderson RE, Barr G, Jakobsson JG (2005) Cerebral state index during anaesthetic induction: a comparative study with propofol or nitrous oxide. Acta Anaesthesiol Scand 49: 750–753
Anderson RE, Jakobsson JG (2004) Entropy of EEG during anaesthetic induction: a comparative study with propofol or nitrous oxide as sole agent. Br J Anaesth 92: 167–170
Antognini JF, Schwartz K (1993) Exaggerated anesthetic requirements in the preferentially anesthetized brain. Anesthesiology 79: 1244–1249
Antognini JF (1993) Hypothermia eliminates isoflurane requirements at 20 degrees C. Anesthesiology 78: 1152–1156
Bailey JM (1989) The pharmacokinetics of volatile anesthetic agent elimination: a theoretical study. J Pharmacokinet Biopharm 17: 109–123
Bailey JM (1997) Context-sensitive half-times and other decrement times of inhaled anesthetics. Anesth Analg 85: 681–686
Bialas P, Ellerkmann R, Bruhn J et al. (2005) Model-independent calculation of ke0 values. Eur J Anaesth [Suppl 34] 22: A-141
Bowerman B, O’Connell R (eds) (1990) Simple coefficients of determination and correlation, linear statistical models (an applied approach). PWS-KENT, Boston, pp 174–183
Bruhn J, Bouillon TW, Shafer SL (2001) Onset of propofol-induced burst suppression may be correctly detected as deepening of anaesthesia by approximate entropy but not by bispectral index. Br J Anaesth 87: 505–507
Bruhn J (2003) Vergleich verschiedener EEG-Parameter: Spektrale Eckfrequenz 95, approximate Entropie und Bispektralindex. Anaesthesiol Intensivmed 44: 17–21
Brunner MD, Braithwaite P, Jhaveri R et al. (1994) MAC reduction of isoflurane by sufentanil. Br J Anaesth 72: 42–46
Cowles AL, Borgstedt HH, Gillies AJ (1971) Tissues weights and rates of blood flow in man for the prediction of anesthetic uptake and distribution. Anesthesiology 35: 523–526
Cranfield KA, Bromley LM (1997) Minimum alveolar concentration of desflurane for tracheal extubation in deeply anaesthetized, unpremedicated children. Br J Anaesth 78: 370–371
Cromwell TH, Eger EI 2nd, Stevens WC, Dolan WM (1971) Forane uptake, excretion, and blood solubility in man. Anesthesiology 35: 401–408
Daniel M, Weiskopf RB, Noorani M, Eger EI 2nd (1998) Fentanyl augments the blockade of the sympathetic response to incision (MAC-BAR) produced by desflurane and isoflurane: desflurane and isoflurane MAC-BAR without and with fentanyl. Anesthesiology 88: 43–49
Davis NR, Mapleson WW (1981) Structure and quantification of a physiological model of the distribution of injected agents and inhaled anaesthetics. Br J Anaesth 53: 399–405
De Jong RH, Eger EI (1975) MAC expanded: AD50 and AD95 values of common inhalation anesthetics in man. Anesthesiology 42: 384–389
Dwyer R, Bennett HL, Eger EI 2nd, Heilbron D (1992) Effects of isoflurane and nitrous oxide in subanesthetic concentrations on memory and responsiveness in volunteers. Anesthesiology 77: 888–898
Eger EI 2nd, Bowland T, Ionescu P et al. (1997) Recovery and kinetic characteristics of desflurane and sevoflurane in volunteers after 8-h exposure, including kinetics of degradation products. Anesthesiology 87: 517–526
Eger EI 2nd, Gong D, Koblin DD et al. (1998) The effect of anesthetic duration on kinetic and recovery characteristics of desflurane versus sevoflurane, and on the kinetic characteristics of compound A, in volunteers. Anesth Analg 86: 414–421
Eger EI 2nd, Johnson BH (1987) MAC of I-653 in rats, including a test of the effect of body temperature and anesthetic duration. Anesth Analg 66: 974–976
Eger EI 2nd, Weiskopf RB, Eisenkraft (2002) The pharmacology of inhaled anesthetics. Br J Anaesth 56: 223–232
Eger EI 3rd (1987) Stability of I-653 in soda lime. Anesth Analg 66: 983–985
Eger EI, Lampe GH, Wauk LZ et al. (1990) Clinical pharmacology of nitrous oxide: an argument for its continued use. Anesth Analg 71: 575–585
Eger EI, Laster MJ, Gregory GA et al. (2003) Women appear to have the same minimum alveolar concentration as men: a retrospective study. Anesthesiology 99: 1059–1061
Eger EI, Saidman LJ, Brandstater B (1965) Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology 26: 756–763
Eger EI (2002) A brief history of the origin of minimum alveolar concentration (MAC). Anesthesiology 96: 238–239
Eger RR, Eger EI 2nd (1985) Effect of temperature and age on the solubility of enflurane, halothane, isoflurane, and methoxyflurane in human blood. Anesth Analg 64: 640–642
Ellerkmann R, Kreuer S, Roepcke H et al. (2005) A model-independent approach estimating ke0 values, describing the equilibration rate constant between plasma and effect-site concentration. Anesthesiology 103: A763
Ellerkmann RK, Liermann VM, Alves TM et al. (2004) Spectral entropy and bispectral index as measures of the electroencephalographic effects of sevoflurane. Anesthesiology 101: 1275–1282
Ellerkmann RK, Soehle M, Alves TM et al. (2006) Spectral entropy and bispectral index as measures of the electroencephalographic effects of propofol. Anesth Analg 102: 1456–1462
Fragen RJ, Dunn KL (1996) The minimum alveolar concentration (MAC) of sevoflurane with and without nitrous oxide in elderly versus young adults. J Clin Anesth 8: 352–356
Gin T, Chan MT (1994) Decreased minimum alveolar concentration of isoflurane in pregnant humans. Anesthesiology 81: 829–832
Glass PS, Bloom M, Kearse L et al. (1997) Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology 86: 836–847
Glass PS (1998) Anesthetic drug interactions: an insight into general anesthesia – its mechanism and dosing strategies. Anesthesiology 88: 5–6
Harris RS, Lazar O, Johansen JW, Sebel PS (2006) Interaction of propofol and sevoflurane on loss of consciousness and movement to skin incision during general anesthesia. Anesthesiology 104: 1170–1175
Hill AV (1910) The possible effect of the aggregration of the molecules of hemoglobin on its dissociation curves. J Physiol 40: iv–vii
Hornbein TF, Eger EI, Winter PM et al. (1982) The minimum alveolar concentration of nitrous oxide in man. Anesth Analg 61: 553–556
Hui TW, Short TG, Hong W et al. (1995) Additive interactions between propofol and ketamine when used for anesthesia induction in female patients. Anesthesiology 82: 641–648
Inomata S, Suwa T, Toyooka H, Suto Y (1998) End-tidal sevoflurane concentration for tracheal extubation and skin incision in children. Anesth Analg 87: 1263–1267
Inomata S, Yaguchi Y, Taguchi M, Toyooka H (1999) End-tidal sevoflurane concentration for tracheal extubation (MACEX) in adults: comparison with isoflurane. Br J Anaesth 82: 852–856
Johansen JW, Sebel PS (2000) Development and clinical application of electroencephalographic bispectrum monitoring. Anesthesiology 93: 1336–1344
Jones RM, Cashman JN, Eger EI 2nd et al. (1990) Kinetics and potency of desflurance (I-653) in volunteers. Anesth Analg 70: 3–7
Katoh T, Bito H, Sato S (2000) Influence of age on hypnotic requirement, bispectral index, and 95% spectral edge frequency associated with sedation induced by sevoflurane. Anesthesiology 92: 55–61
Katoh T, Ikeda K, Bito H (1997) Does nitrous oxide antagonize sevoflurane-induced hypnosis? Br J Anaesth 79: 465–468
Katoh T, Ikeda K (1987) The minimum alveolar concentration (MAC) of sevoflurane in humans. Anesthesiology 66: 301–303
Katoh T, Ikeda K (1998) The effects of fentanyl on sevoflurane requirements for loss of consciousness and skin incision. Anesthesiology 88: 18–24
Katoh T, Kobayashi S, Suzuki A et al. (1999) The effect of fentanyl on sevoflurane requirements for somatic and sympathetic responses to surgical incision. Anesthesiology 90: 398–405
Katoh T, Suguro Y, Ikeda T et al. (1993) Influence of age on awakening concentrations of sevoflurane and isoflurane. Anesth Analg 76: 348–352
Katoh T, Uchiyama T, Ikeda K (1994) Effect of fentanyl on awakening concentration of sevoflurane. Br J Anaesth 73: 322–325
Keller O, Kreuer S, Bruhn J et al. (2006) The accuracy of two pharmacokinetic data sets for propofol. Eur J Anaesth [Suppl 37] 23: A-513
Kennedy RR, French RA, Gilles S (2004) The effect of a model-based predictive display on the control of end-tidal sevoflurane concentrations during low-flow anesthesia. Anesth Analg 99: 1159–1163
Kennedy RR, French RA, Spencer C (2002) Predictive accuracy of a model of volatile anesthetic uptake. Anesth Analg 95: 1616–1621
Kennedy RR (2005) The effect of using different values for the effect-site equilibrium half-time on the prediction of effect-site sevoflurane concentration: a simulation study. Anesth Analg 101: 1023–1028
Kihara S, Yaguchi Y, Inomata S et al. (2003) Influence of nitrous oxide on minimum alveolar concentration of sevoflurane for laryngeal mask insertion in children. Anesthesiology 99: 1055–1058
Kissin I (2000) Depth of anesthesia and bispectral index monitoring. Anesth Analg 90: 1114–1117
Kreuer S, Bruhn J, Grundmann U et al. (2005) Comparison of 2 pharmacodynamic EEG models with and without a pharmacodynamic plateau. Eur J Anaesth 22 [Suppl 34]: A-100
Kreuer S, Wilhelm W (2006) The Narcotrend Monitor. Best Pract Res Clin Anaesthesiol 20: 111–119
Kreuer S, Bialas P, Bruhn J et al. (2005) Application of bispectral and narcotrend indices to the measurement of the electroencephalographic effects of desflurane. Anesthesiology 103: A820
Kreuer S, Biedler A, Larsen R et al. (2003) Narcotrend monitoring allows faster emergence and a reduction of drug consumption in propofol-remifentanil anesthesia. Anesthesiology 99: 34–41
Kreuer S, Bruhn J, Biedler A et al. (2005) Dose-response relationship between sevoflurane concentrations and Narcotrend or bispectral index. Eur J Anaesth 22 [Suppl 34]: A-119
Kreuer S, Bruhn J, Biedler S et al. (2006) ke0 values for propofol using different PK/PD data sets. Eur J Anaesth 23 [Suppl 37]: A-120
Kreuer S, Bruhn J, Buchinger H et al. (2005) Dose-response relationship between sevoflurane concentrations and Narcotrend index. Anesthesiology 103: A823
Kreuer S, Bruhn J, Larsen R et al. (2004) Comparison of BIS and AAI as measures of anaesthetic drug effect during desflurane-remifentanil anaesthesia. Acta Anaesthesiol Scand 48: 1168–1173
Kreuer S, Bruhn J, Larsen R et al. (2004) Application of Narcotrend index and bispectral index to the measurement of the EEG effects of isoflurane with and without burst suppression. Anesthesiology 101: 847–854
Kreuer S, Bruhn J, Larsen R et al. (2005) Pharmakodynamisches Plateau im prozessierten EEG bei Sevofluran-Anästhesien. Wissenschaftliche Arbeitstage der DGAI, Würzburg
Kreuer S, Wilhelm W, Grundmann U et al. (2004) Narcotrend index vs. bispectral index as EEG measures of anesthetic drug effect during propofol anesthesia. Anesth Analg 98: 692–697
Lang E, Kapila A, Shlugman D et al. (1996) Reduction of isoflurane minimal alveolar concentration by remifentanil. Anesthesiology 85: 721–728
LeDez KM, Lerman J (1987) The minimum alveolar concentration (MAC) of isoflurane in preterm neonates. Anesthesiology 67: 301–307
Lerman J, Gregory GA, Eger EI 2nd (1984) Hematocrit and the solubility of volatile anesthetics in blood. Anesth Analg 63: 911–914
Lerman J, Schmitt-Bantel BI, Gregory GA et al. (1986) Effect of age on the solubility of volatile anesthetics in human tissues. Anesthesiology 65: 307–311
Lerman J, Willis MM, Gregory GA, Eger EI 2nd (1983) Osmolarity determines the solubility of anesthetics in aqueous solutions at 37 degrees C. Anesthesiology 59: 554–558
Lerou JG, Dirksen R, Beneken Kolmer HH et al. (1991) A system model for closed-circuit inhalation anesthesia. II. Clinical validation. Anesthesiology 75: 230–237
Lerou JG, Dirksen R, Beneken Kolmer HH, Booij LH (1991) A system model for closed-circuit inhalation anesthesia. I. Computer study. Anesthesiology 75: 345–355
Lerou JG (2004) Nomogram to estimate age-related MAC. Br J Anaesth 93: 288–291
Levitt DG (2002) PKQuest: volatile solutes – application to enflurane, nitrous oxide, halothane, methoxyflurane and toluene pharmacokinetics. BMC Anesthesiology 2: 5
Locher S, Stadler KS, Boehlen T et al. (2004) A new closed-loop control system for isoflurane using bispectral index outperforms manual control. Anesthesiology 101: 591–602
Lockwood GG, Sapsed-Byrne SM, Smith MA (1997) Effect of temperature on the solubility of desflurane, sevoflurane, enflurane and halothane in blood. Br J Anaesth 79: 517–520
Loomis AL, Harvey EN, Hobart CA (1937) Cerebral states during sleep as studied by human brain potentials. J Exp Psychol 21: 127–144
Malviya S, Lerman J (1990) The blood/gas solubilities of sevoflurane, isoflurane, halothane, and serum constituent concentrations in neonates and adults. Anesthesiology 72: 793–796
Mapleson WW (1996) Effect of age on MAC in humans: a meta-analysis. Br J Anaesth 76: 179–185
Marsh B, White M, Morton N, Kenny GN (1991) Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 67: 41–48
McEwan AI, Smith C, Dyar O et al. (1993) Isoflurane minimum alveolar concentration reduction by fentanyl. Anesthesiology 78: 864–869
McKay ID, Voss LJ, Sleigh JW et al. (2006) Pharmacokinetic-pharmacodynamic modeling the hypnotic effect of sevoflurane using the spectral entropy of the electroencephalogram. Anesth Analg 102: 91–97
Nakajima R, Nakajima Y, Ikeda K (1993) Minimum alveolar concentration of sevoflurane in elderly patients. Br J Anaesth 70: 273–275
Nickalls RW, Mapleson WW (2003) Age-related iso-MAC charts for isoflurane, sevoflurane and desflurane in man. Br J Anaesth 91: 170–174
Olofsen E, Dahan A (1999) The dynamic relationship between end-tidal sevoflurane and isoflurane concentrations and bispectral index and spectral edge frequency of the electroencephalogram. Anesthesiology 90: 1345–1353
Olofsen E, Sleigh JW, Dahan A (2002) The influence of remifentanil on the dynamic relationship between sevoflurane and surrogate anesthetic effect measures derived from the EEG. Anesthesiology 96: 555–564
Rampil IJ, Lockhart SH, Zwass MS et al. (1991) Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. Anesthesiology 74: 429–433
Rampil IJ, Mason P, Singh H (1993) Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology 78: 707–712
Rampil IJ (1994) Anesthetic potency is not altered after hypothermic spinal cord transection in rats. Anesthesiology 80: 606–610
Rampil IJ (1998) A primer for electroencephalogram signal processing in anesthesia. Anesthesiology 89: 980–1002
Rehberg B, Bouillon T, Zinserling J, Hoeft A (1999) Comparative pharmacodynamic modeling of the electroencephalography-slowing effect of isoflurane, sevoflurane, and desflurane. Anesthesiology 91: 397–405
Rietbrock S, Wissing H, Kuhn I, Fuhr U (2000) Pharmacokinetics of inhaled anaesthetics in a clinical setting: description of a novel method based on routine monitoring data. Br J Anaesth 84: 437–442
Roizen MF, Horrigan RW, Frazer BM (1981) Anesthetic doses blocking adrenergic (stress) and cardiovascular responses to incision – MAC BAR. Anesthesiology 54: 390–398
Ropcke H, Konen-Bergmann M, Cuhls M et al. (2001) Propofol and remifentanil pharmacodynamic interaction during orthopedic surgical procedures as measured by effects on bispectral index. J Clin Anesth 13: 198–207
Ropcke H, Lier H, Hoeft A, Schwilden H (1999) Isoflurane, nitrous oxide, and fentanyl pharmacodynamic interactions in surgical patients as measured by effects on median power frequency. J Clin Anesth 11: 555–562
Ropcke H, Schwilden H (1996) Die Interaktion von Stickoxidul und Enfluran bei einem EEG-Median von 2–3 Hz ist additiv, aber schwacher als bei 1,0 MAC. Anaesthesist 45: 819–825
Ropcke H, Schwilden H (1996) Interaction of isoflurane and nitrous oxide combinations similar for median electroencephalographic frequency and clinical anesthesia. Anesthesiology 84: 782–788
Ropcke H, Wirz S, Bouillon T et al. (2001) Pharmacodynamic interaction of nitrous oxide with sevoflurane, desflurane, isoflurane and enflurane in surgical patients: measurements by effects on EEG median power frequency. Eur J Anaesthesiol 18: 440–449
Russell GB, Snider MT, Richard RB, Loomis JL (1990) Hyperbaric nitrous oxide as a sole anesthetic agent in humans. Anesth Analg 70: 289–295
Saidman LJ, Eger EI (1964) Effect of nitrous oxide and of narcotic premedication on the alveolar concentration of halothane required for anesthesia. Anesthesiology 25: 302–306
Scheller MS, Saidman LJ, Partridge BL (1988) MAC of sevoflurane in humans and the New Zealand white rabbit. Can J Anaesth 35: 153–156
Schmidt GN, Bischoff P, Standl T et al. (2002) Narcotrend, bispectral index, and classical electroencephalogram variables during emergence from propofol/remifentanil anesthesia. Anesth Analg 95: 1324–1330
Schnider TW, Minto CF, Gambus PL et al. (1998) The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 88: 1170–1182
Schultz B, Kreuer S, Wilhelm W et al. (2003) The Narcotrend monitor. Development and interpretation algorithms. Anaesthesist 52: 1143–1148
Schwilden H, Ropcke H, Drosler S (1995) Die klinische Potenz von Stickoxidul – Ist MAC der Goldstandard? Anasthesiol Intensivmed Notfallmed Schmerzther 30: 337–340
Schwilden H, Schüttler J, Stoeckel H (1987) Closed-loop feedback control of methohexital anesthesia by quantitative EEG analysis in humans. Anesthesiology 67: 341–347
Schwilden H, Stoeckel H (1987) Quantitative EEG analysis during anaesthesia with isoflurane in nitrous oxide at 1.3 and 1.5 MAC. Br J Anaesth 59: 738–745
Shafer SL (2004) Pharmacokinetic and pharmacodynamic analysis with NONMEM – basic concepts. Workshop, Palo Alto, California, USA, 9.17
Smith WD, Dutton RC, Smith NT (1996) Measuring the performance of anesthetic depth indicators. Anesthesiology 84: 38–51
Stevens WD, Dolan WM, Gibbons RT et al. (1975) Minimum alveolar concentrations (MAC) of isoflurande with and without nitrous oxide in patients of various ages. Anesthesiology 42: 197–200
Strum DP, Eger EI 2nd (1987) Partition coefficients for sevoflurane in human blood, saline, and olive oil. Anesth Analg 66: 654–656
Swan HD, Crawford MW, Pua HL et al. (1999) Additive contribution of nitrous oxide to sevoflurane minimum alveolar concentration for tracheal intubation in children. Anesthesiology 91: 667–671
Taheri S, Eger EI 2nd (1999) A demonstration of the concentration and second gas effects in humans anesthetized with nitrous oxide and desflurane. Anesth Analg 89: 774–780
Torri G, Damia G, Fabiani ML (1974) Effect on nitrous oxide on the anaesthetic requirement of enflurane. Br J Anaesth 46: 468–472
Wadhwa A, Durrani J, Sengupta P et al. (2003) Women have the same desflurane minimum alveolar concentration as men: a prospective study. Anesthesiology 99: 1062–1065
Westmoreland CL, Sebel PS, Gropper A (1994) Fentanyl or alfentanil decreases the minimum alveolar anesthetic concentration of isoflurane in surgical patients. Anesth Analg 78: 23–28
Wilhelm W, Kreuer S (2003) Das interpretierte EEG als Überwachungsverfahren in der Anästhesiologie. Anasthesiol Intensivmed 44: 8–15
Yasuda N, Lockhart SH, Eger EI 2nd et al. (1991) Kinetics of desflurane, isoflurane, and halothane in humans. Anesthesiology 74: 489–498
Yasuda N, Lockhart SH, Eger EI 2nd et al. (1991) Comparison of kinetics of sevoflurane and isoflurane in humans. Anesth Analg 72: 316–324
Yasuda N, Targ AG, Eger EI et al. (1990) Pharmacokinetics of desflurane, sevoflurane, isoflurane, and halothane in pigs. Anesth Analg 71: 340–348
Yasuda N, Targ AG, Eger El (1989) Solubility if I-653, sevoflurane, isoflurane, and halothane in human tissues. Anesth Analg 69: 370–373
Yasuda N, Weiskopf RB, Cahalan MK et al. (1991) Does desflurane modify circulatory responses to stimulation in humans? Anesth Analg. 73: 175–179
Zbinden AM, Maggiorini M, Petersen-Felix S et al. (1994) Anesthetic depth defined using multiple noxious stimuli during isoflurane/oxygen anesthesia. I. Motor reactions. Anesthesiology 80: 253–260
Zhou JX, Liu J (2001) The effect of temperature on solubility of volatile anesthetics in human tissues. Anesth Analg 93: 234–238
Interessenkonflikt
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kreuer, S., Bruhn, J., Wilhelm, W. et al. Pharmakokinetische/pharmakodynamische Modelle für Inhalationsanästhetika. Anaesthesist 56, 538–556 (2007). https://doi.org/10.1007/s00101-007-1188-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00101-007-1188-7